Mineralys Therapeutics, Inc. (MLYS)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Mineralys Therapeutics, Inc.’s filings yet. We add companies and filings all the time.
Track MLYS and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $158.83M |
| FMR LLC | Aug 13, 2026 | $121.73M |
| STATE STREET CORPORATION | Sep 22, 2026 | $111.74M |
| Vanguard Capital Management | Aug 13, 2026 | $74.38M |
| T. Rowe Price Associates, Inc. | Aug 14, 2026 | $61.04M |
MLYS's filings are public. The insight is one click away.
Scrutar's AI reads every MLYS filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a MLYS filing.
Get an email when MLYS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 9, 2026Source: SEC EDGAR.